One botanical earned a head-to-head against a hair-loss drug and held its ground. Rosemary oil. The trial is real and cited 97 times in the scientific literature. It is also more modest than the internet makes it sound. Here is the honest read.
Rosemary is the single best-evidenced plant active in our hair portfolio. That is precisely why we will not inflate it. The trial is good enough to stand on its own terms, so let us walk through exactly what it found.
The Panahi 2015 Trial, As It Happened
In 2015, Panahi and colleagues published a randomised comparative trial in the journal Skinmed. They enrolled 100 men with androgenetic alopecia, the standard pattern hair loss.
One group used topical rosemary oil. The other used 2% minoxidil. The trial ran six months, with hair count measured at the start, at three months and at six months.
Both groups significantly increased hair count from baseline by month six. The difference between rosemary and 2% minoxidil was not statistically significant. In plain terms: rosemary matched the 2% minoxidil arm on the primary measure.
There was one clear edge for rosemary. Scalp itching was significantly less frequent in the rosemary group at three and six months. The authors were academic, and the trial declared no pharmaceutical-industry funding.
That independence matters. A botanical matching a drug, in a study with no pharma money behind it, is a stronger receipt than a supplier brochure. It is why this single paper carries so much weight in the conversation about plant actives for hair.
Read the Fine Print Before You Switch
This trial is strong, but it is specific. Three details matter, and we will not bury them.
First, the comparator was 2% minoxidil, not the stronger 5% formulation many people use. Rosemary matched the lower dose. The study does not test it against 5%.
Second, the design was single-blind, not double-blind. That is a real but lesser tier of rigour, and we report it as such.
Third, the cohort was 100 men with pattern hair loss, by design. The result does not extend to non-pattern shedding, and it was not measured in women.
None of this sinks the trial. It just sets the boundary of what it proves. We would rather you know that boundary than discover it after six months of use.
How Rosemary Is Thought to Work
The leading mechanism is 5-alpha-reductase inhibition, the same enzyme target behind DHT-driven thinning. Rosemary leaf extract inhibited that enzyme and promoted regrowth in a mouse model, driven by 12-methoxycarnosic acid (Murata 2013).
This connects the two trials. If rosemary blunts the DHT pathway, that is a plausible reason it tracked a drug which works further down the same hormonal cascade. The two findings point in a consistent direction.
Keep the altitude honest here. That mechanism is in-vitro plus a mouse model, not a human mechanism readout. We do not claim rosemary "reactivates microcirculation" in people, because the proven mechanism is enzyme inhibition, not blood flow.
Cell-screening work on hair-active compounds exists too (Huh 2009), but that paper is a cell-based screening assay, and we cite it only as that. We do not pin specific TGF-beta or 5-alpha-reductase mechanisms to it. A screening tool tells you a method works, not that any one ingredient does.
Where Peptides Come In
Rosemary is the botanical with the human trial. The routine pairs it with a peptide stack to address thinning from a second angle: follicle anchoring and anagen-phase density.
The serum's Procapil and Redensyl figures come from supplier in-vivo studies, which are manufacturer-funded. We disclose that plainly. Independent human data sits with rosemary; the peptides add a complementary, supplier-tested mechanism.
This is the brand's whole logic in one product: a validated botanical and an advanced active, working through different routes. Two mechanisms covering more of the problem than either could alone.
What Rosemary + Peptides Does
- Pairs a botanical with a 100-person human trial (rosemary) and a follicle-targeting peptide stack.
- Addresses pattern thinning through enzyme inhibition plus anchoring and anagen support.
- Tends to irritate the scalp less than minoxidil, which itched more in the trial.
- Works as a maintenance routine: hold ground, regain modestly over months.
What It Does Not Do
- It is not an overnight cure. Hair count moved over months, not weeks.
- It did not beat minoxidil. It matched a 2% dose, and was not tested against 5%.
- It is not proven for non-pattern shedding, and the trial enrolled men only.
How to Use It
Cleanse at the scalp first to clarify buildup. Apply the serum along part lines and massage 60 to 90 seconds, so actives reach the follicle. Then hold the routine for at least three to six months.
Set the expectation honestly: maintenance first, modest regain second. Hair you keep is hair you do not have to regrow. On independent data, rosemary is one of the best-evidenced plant actives in hair care, and that is enough.
Frequently asked questions
Is rosemary oil as effective as minoxidil for hair loss?
In one trial it matched the lower dose. Panahi 2015 (PMID 25842469) randomised 100 men with androgenetic alopecia to rosemary oil or 2% minoxidil for six months. Both raised hair count from baseline, with no statistically significant difference between them, and rosemary caused less scalp itch. Important caveat: the comparator was 2% minoxidil, not 5%, and the study was single-blind, so this matches a lower-strength dose rather than beating the drug.
How long does rosemary oil take to work on hair?
Months, not weeks. In the Panahi trial, hair count was measured at baseline, three months and six months, and the significant increase showed by month six. Follicle cycles are slow, so realistic use is a sustained routine over three to six months at minimum. It is best understood as maintenance with modest regain, not a fast fix.
How is rosemary oil thought to fight hair loss?
The leading mechanism is 5-alpha-reductase inhibition, the same enzyme target behind DHT-driven follicle miniaturisation. Rosemary leaf extract inhibited that enzyme and promoted regrowth in a mouse model via 12-methoxycarnosic acid (Murata 2013, PMID 22517595). This mechanism is in-vitro plus a mouse model, not a human mechanism readout, so we describe it as a plausible pathway rather than a proven human effect.
Can rosemary oil cure hair loss completely?
No. The evidence supports maintenance and modest regain in pattern hair loss, not a cure. The Panahi trial was single-blind, enrolled 100 men only, and compared rosemary with 2% minoxidil rather than the stronger 5% formulation. It does not establish regrowth in non-pattern shedding, and it was not tested in women. We present rosemary as a well-evidenced botanical, used realistically over months.
